Nebenwirkungen · Levetiracetam ratiopharm
Levetiracetam ratiopharm 250 mg film-coated tablets Levetiracetam ratiopharm 500 mg film-coated tablets Levetiracetam ratiopharm 750 mg film-coated tablets Levetiracetam ratiopharm 1000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10–11
HOS-213818 · Präparat HOS-155212
10 Frequency category MedDRA SOC Very Common Uncommon Rare Very rare common Respiratory, Cough thoracic and mediastinal disorders Gastrointestinal Abdominal Pancreatitis disorders pain, diarrhoea, dyspepsia, vomiting, nausea Hepatobiliary Liver function Hepatic failure, disorders test abnormal hepatitis Renal and Acute Kidney Urinary injury Disorders Skin and Rash Alopecia, Toxic epidermal subcutaneous eczema, necrolysis, tissue disorders pruritus, Stevens-Johnson syndrome, erythema multiforme Musculoskeleta Muscular Rhabdomyolysis l and weakness, and blood connective myalgia creatine tissue disorders phosphokinase increased(3) General Asthenia/ disorders and fatigue administration site conditions Injury, Injury poisoning and procedural complications (1) See Description of selected adverse reactions. (2) Very rare cases of development of obsessive-compulsive disorders (OCD) in patients with underlying history of OCD or psychiatric disorders have been observed in post-marketing surveillance. (3) Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-26T17:59:00Z · SHA-256 f83b9a6129b8ef5144ae86c3c40558f640cbeaa7f135ea04834f52af3d8864f5 · Passage 0d39fca851b895a5cd9ace225e1851e7dc3c1201895ef810225a3edb60f00d05 · Zeichen 4906–7308 im Abschnitt